Abstract
Precisely how regulated patterns of gene expression under the control of diverse signaling pathways underlie the homeostatic control of neuroanatomical aspects of cardiac function remains unclear. The autonomic nervous system is distinguished by the sympathetic and parasympathetic nervous systems that are under the direct control of transcription factors that function as either activators or repressors of gene expression. While several regulatory determinants are known to coordinate the actions of activators and repressors, how these factors serve to maintain genes implicated in the neurocardiac axis is the subject of review. The discovery of regulatory complexes that serve as a functional linkage between DNA-bound transcription factors and altered chromatin structures indicates that posttranslational modifications of core histones connect aspects of neurocardiac gene function. The complexity of these regulators to alter noradrenaline transporter (NET) gene function is explored here. Recent evidence of chromatin-modifying enzymes regulating NET expression might apply to genes implicated in neurocardiology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akbarian, S., & Nestler, E. J. (2013). Epigenetic mechanisms in psychiatry. Neuropsychopharmacology, 38(1), 1–2.
Alvarenga, M. E., Richards, J. C., Lambert, G., & Esler, M. D. (2006). Psychophysiological mechanisms in panic disorder: A correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosomatic Medicine, 68(1), 8–16.
Anonymous. (2004). The ENCODE (ENCyclopedia Of DNA Elements) project. Science, 306(5696):636–640.
Anway, M. D., Cupp, A. S., Uzumcu, M., & Skinner, M. K. (2005). Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science, 308(5727), 1466–1469.
Aranyi, T., et al. (2005). The tissue-specific methylation of the human tyrosine hydroxylase gene reveals new regulatory elements in the first exon. Journal of Neurochemistry, 94(1), 129–139.
Banfai, B., et al. (2012). Long noncoding RNAs are rarely translated in two human cell lines. Genome Research, 22(9), 1646–1657.
Barton, D. A., et al. (2007). Sympathetic activity in major depressive disorder: Identifying those at increased cardiac risk?. Journal of Hypertension, 25(10), 2117–2124.
Barton, D. A., et al. (2008). Elevated brain serotonin turnover in patients with depression: Effect of genotype and therapy. Archives of General Psychiatry, 65(1), 38–46.
Bayles, R., Baker, E., Eikelis, N., El-Osta, A., & Lambert, G. (2010). Histone modifications regulate the norepinephrine transporter gene. Cell Cycle, 9(22), 4600–4601.
Bayles, R., et al. (2012). Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(8), 1910–1916.
Bayles, R., et al. (2013). Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One, 8(12), e83223.
Bonisch, H., & Bruss, M. (2006). The norepinephrine transporter in physiology and disease. Handbook of Experimental Pharmacology, 175, 485–524.
Boomsma, D. I., et al. (2008). Genome-wide association of major depression: Description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. European Journal of Human Genetics: EJHG, 16(3), 335–342.
Bosker, F. J., et al. (2011). Poor replication of candidate genes for major depressive disorder using genome-wide association data. Molecular Psychiatry, 16(5), 516–532.
Bresee, L. C., Majumdar, S. R., Patten, S. B., & Johnson, J. A. (2010). Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study. Schizophrenia Research, 117(1), 75–82.
Brown, M. R., & Fisher, L. A. (1986). Glucocorticoid suppression of the sympathetic nervous system and adrenal medulla. Life Sciences, 39(11), 1003–1012.
Carvalho, L. A., et al. (2014). Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Translational Psychiatry, 4, e344.
Casper, R. C., et al. (1985). Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Archives of General Psychiatry, 42(11), 1098–1104.
Chang, C. C., et al. (2007). Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. Journal of Psychiatry and Neuroscience, 32(2), 121–128.
Chien, I. C., et al. (2009). Prevalence of diabetes in patients with schizophrenia in Taiwan: A population-based National Health Insurance study. Schizophrenia Research, 111(1-3), 17–22.
Clark, C. G., Hasser, E. M., Kunze, D. L., Katz, D. M., & Kline, D. D. (2011). Endogenous brain-derived neurotrophic factor in the nucleus tractus solitarius tonically regulates synaptic and autonomic function.. The Journal of Neuroscience, 31(34), 12318–12329.
Covington, H. E., 3rd, et al. (2011). A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron, 71(4), 656–670.
Dawood, T., et al. (2007). Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Molecular Psychiatry, 12(11), 981–983.
Djebali, S., et al. (2012). Landscape of transcription in human cells. Nature, 489(7414), 101–108.
Duman, R. S., & Li, N. (2012). A neurotrophic hypothesis of depression: Role of synaptogenesis in the actions of NMDA receptor antagonists. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 367(1601), 2475–2484.
Duncan, L. E., Hutchison, K. E., Carey, G., & Craighead, W. E. (2009). Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. Journal of Affective Disorders, 115(1–2), 215–219.
Eikelis, N., & Esler, M. (2005). The neurobiology of human obesity. Experimental Physiology, 90(5), 673–682.
Eisenhofer, G., et al. (1996). Cardiac sympathetic nerve function in congestive heart failure. Circulation, 93(9), 1667–1676.
Esler, M. (1993). Clinical application of noradrenaline spillover methodology: Delineation of regional human sympathetic nervous responses. Pharmacology & Toxicology, 73(5), 243–253.
Esler, M., et al. (1980). Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension. Clinical Science (London), 59(Suppl 6), 311s–313s. in eng.
Esler, M. D., et al. (1991). Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. The American Journal of Physiology, 260(4 Pt 2), R817–R823.
Esler, M. D., et al. (1995). Aging effects on human sympathetic neuronal function. The American Journal of Physiology, 268(1 Pt 2), R278–R285.
Esler, M., et al. (2002a). Influence of ageing on the sympathetic nervous system and adrenal medulla at rest and during stress. Biogerontology, 3(1–2), 45–49.
Esler, M., et al. (2002b). The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology, 282(3), R909–R916.
Esler, M., et al. (2006). The neuronal noradrenaline transporter, anxiety and cardiovascular disease. Journal of Psychopharmacology, 20(4 Suppl), 60–66.
Esler, M., et al. (2008). Human sympathetic nerve biology: Parallel influences of stress and epigenetics in essential hypertension and panic disorder. Annals of the New York Academy of Sciences, 1148, 338–348.
Fuchikami, M., Morinobu, S., Kurata, A., Yamamoto, S., & Yamawaki, S. (2009). Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. International Journal of Neuropsychopharmacology, 12(1), 73–82.
Gerson, M. C., et al. (2002). Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. Journal of Nuclear Cardiology, 9(6), 608–615.
Grunau, C., Hindermann, W., & Rosenthal, A. (2000). Large-scale methylation analysis of human genomic DNA reveals tissue-specific differences between the methylation profiles of genes and pseudogenes. Human Molecular Genetics, 9(18), 2651–2663.
Habecker, B. A., Willison, B. D., Shi, X., & Woodward, W. R. (2006). Chronic depolarization stimulates norepinephrine transporter expression via catecholamines. Journal of Neurochemistry, 97(4), 1044–1051.
Halushka, M. K., et al. (1999). Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nature Genetics, 22(3), 239–247.
Harikrishnan, K. N., et al. (2010). Alleviating transcriptional inhibition of the norepinephrine slc6a2 transporter gene in depolarized neurons. The Journal of Neuroscience, 30(4), 1494–1501.
Harrow, J., et al. (2012). GENCODE: The reference human genome annotation for the ENCODE project. Genome Research, 22(9), 1760–1774.
Hejjas, K., et al. (2009). Association between depression and the Gln460Arg polymorphism of P2RX7 gene: A dimensional approach. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B(2), 295–299.
Henikoff, S., & Matzke, M. A. (1997). Exploring and explaining epigenetic effects. Trends in Genetics, 13(8), 293–295.
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115–1121.
Inoue, K., Itoh, K., Yoshida, K., Shimizu, T., & Suzuki, T. (2004). Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a japanese population. Neuropsychobiology, 50(4), 301–304.
Inoue, K., et al. (2007). No association of the G1287A polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a japanese population. Biological and Pharmaceutical Bulletin, 30(10), 1996–1998.
Jia, Z. Y., et al. (2011). In vitro and in vivo studies of adenovirus-mediated human norepinephrine transporter gene transduction to hepatocellular carcinoma. Cancer Gene Therapy, 18(3), 196–205.
Karg, K., Burmeister, M., Shedden, K., & Sen, S. (2011). The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation. Archives of General Psychiatry, 68(5), 444–454.
Kaye, D. M., et al. (1994). Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. Journal of the American College of Cardiology, 23(3), 570–578.
Keller, J., et al. (2000). Neuropsychological differentiation of depression and anxiety. Journal of Abnormal Psychology, 109(1), 3–10.
Keller, S., et al. (2010). Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Archives of General Psychiatry, 67(3), 258–267.
Kilpinen, H., et al. (2008). Association of DISC1 with autism and Asperger syndrome. Molecular Psychiatry, 13(2), 187–196.
Ksiazek, P., Buraczynska, K., & Buraczynska, M. (2006). Norepinephrine transporter gene (NET) polymorphism in patients with type 2 diabetes. Kidney and Blood Pressure Research, 29(6), 338–343.
Labonte, B., Azoulay, N., Yerko, V., Turecki, G., & Brunet, A. (2014). Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder. Translational Psychiatry, 4, e368.
Lambert, G., & Grassi, G. (2010). Indices of sympathetic activity and the paradox of chromogranin A. Journal of Hypertension, 28(4), 676–678.
Lambert, E., et al. (2006). Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. The Journal of Physiology, 570(Pt 3), 637–643.
Lambert, E., et al. (2007a). Gender differences in sympathetic nervous activity: Influence of body mass and blood pressure. Journal of Hypertension, 25(7), 1411–1419.
Lambert, E., et al. (2007b). Psychological stress and the development of heart disease. Current Psychiatry Reviews, 3(4), 252–258.
Lambert, E., et al. (2008a). Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clinical and Experimental Pharmacology and Physiology, 35(4), 503–507.
Lambert, E., et al. (2008b). Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circulation. Arrhythmia and Electrophysiology, 1(2), 103–109.
Lambert, E., et al. (2010). Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. Journal of Hypertension, 28(3), 543–550.
Lin, P. I., & Shuldiner, A. R. (2010). Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes. Schizophrenia Research, 123(2–3), 234–243.
McGowan, P. O., et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience, 12(3), 342–348.
Meredith, I. T., et al. (1991). Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clinical Autonomic Research, 1(3), 187–194.
Mill, J., & Petronis, A. (2007). Molecular studies of major depressive disorder: The epigenetic perspective. Molecular Psychiatry, 12(9), 799–814.
Montag, C., Basten, U., Stelzel, C., Fiebach, C. J., & Reuter, M. (2010). The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans. Psychiatry Research, 179(1), 86–90.
More, S. S., et al. (2011). Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems. Clinical Cancer Research, 17(8), 2339–2349.
Neph, S., et al. (2012). An expansive human regulatory lexicon encoded in transcription factor footprints. Nature, 489(7414), 83–90.
Niwa, M., et al. (2010). Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron, 65(4), 480–489.
Niwa, M., et al. (2013). Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science, 339(6117), 335–339.
Okada, S., et al. (2012). Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(8), 1902–1909.
Ono, K., et al. (2003). Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertension Research, 26(9), 685–689.
Petersson, M. J., et al. (2002). Increased cardiac sympathetic drive in renovascular hypertension. Journal of Hypertension, 20(6), 1181–1187.
Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010). Epigenetic phenomena linked to diabetic complications. Nature Reviews Endrocrinology, 6(12), 665–675.
Pirola, L., et al. (2011). Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Research, 21(10), 1601–1615.
Prokunina, L., & Alarcn-Riquelme, M. E. (2004). Regulatory SNPs in complex diseases: Their identification and functional validation. Expert Reviews in Molecular Medicine, 2004, 1–15.
Rafehi, H., et al. (2014). Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Research, 24(8), 1271–1284.
Ryu, S. H., et al. (2004). Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology, 49(4), 174–177.
Schlaich, M. P., et al. (2004). Sympathetic augmentation in hypertension: Role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension, 43(2), 169–175.
Schroeder, C., et al. (2004). Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology, 286(5), R851–R856.
Sevoz-Couche, C., et al. (2013). Involvement of the dorsomedial hypothalamus and the nucleus tractus solitarii in chronic cardiovascular changes associated with anxiety in rats. Journal of Physiology, 591(Pt 7), 1871–1887.
Song, Y., et al. (2014). Altered DNA methylation status of human brain derived neurotrophic factor gene could be useful as biomarker of depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 165(4), 357–364.
St Clair, D., et al. (1990). Association within a family of a balanced autosomal translocation with major mental illness. Lancet, 336(8706), 13–16.
Stachowiak, M. K., Rigual, R. J., Lee, P. H., Viveros, O. H., & Hong, J. S. (1988). Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferase mRNA levels in the sympathoadrenal system by the pituitary-adrenocortical axis. Brain Research, 427(3), 275–286.
Sugawara, H., et al. (2011). Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. Translational Psychiatry, 1, e24.
Thomson, P. A., et al. (2005). Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Molecular Psychiatry, 10(7), 657–668, 616.
Thurman, R. E., et al. (2012). The accessible chromatin landscape of the human genome. Nature, 489(7414), 75–82.
Tsankova, N. M., Kumar, A., & Nestler, E. J. (2004). Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. The Journal of Neuroscience, 24(24), 5603–5610.
Tsankova, N. M., et al. (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nature Neuroscience, 9(4), 519–525.
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007). Epigenetic regulation in psychiatric disorders. Nature Review Neuroscience, 8(5), 355–367.
Turner, A. M., & Morris, K. V. (2010). Controlling transcription with noncoding RNAs in mammalian cells. Biotechniques, 48(6), ix–xvi.
Vucetic, Z., Carlin, J. L., Totoki, K., & Reyes, T. M. (2012). Epigenetic dysregulation of the dopamine system in diet-induced obesity. Journal of Neurochemistry, 120(6), 891–898.
Walker, M. P., LaFerla, F. M., Oddo, S. S., & Brewer, G. J. (2013). Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer’s disease. Age (Dordrecht, Netherlands), 35(3), 519–531.
Wang, J., et al. (2012a). Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Research, 22(9), 1798–1812.
Wang, H., et al. (2012b). Widespread plasticity in CTCF occupancy linked to DNA methylation. Genome Research, 22(9), 1680–1688.
Wankerl, M., et al. (2014). Effects of genetic and early environmental risk factors for depression on serotonin transporter expression and methylation profiles. Translational Psychiatry, 4, e402.
Weaver, I. C., et al. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7(8), 847–854.
Wilkinson, D. J., et al. (1998). Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Archives of General Psychiatry, 55(6), 511–520.
Wray, N. R., et al. (2012). Genome-wide association study of major depressive disorder: New results, meta-analysis, and lessons learned. Molecular Psychiatry, 17(1), 36–48.
Yang, A. C., et al. (2010). BDNF Val66Met polymorphism alters sympathovagal balance in healthy subjects. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153B(5), 1024–1030.
Yano, T., Yamabe, H., & Yokoyama, M. (1999). Washout rate of 123I-metaiodobenzylguanidine increased by posture change or exercise in normal volunteers. Annals of Nuclear Medicine, 13(2), 89–93.
Yip, K. Y., et al. (2012). Classification of human genomic regions based on experimentally determined binding sites of more than 100 transcription-related factors. Genome Biology, 13(9), R48.
Yoh, M., et al. (2009). Resting muscle sympathetic nerve activity, cardiac metaiodobenzylguanidine uptake, and exercise tolerance in patients with left ventricular dysfunction. Journal of Nuclear Cardiology, 16(2), 244–250.
Zill, P., et al. (2002). Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology, 26(4), 489–493.
Zolk, O., Ott, C., Fromm, M. F., & Schmieder, R. E. (2012). Effect of the rs168924 single-nucleotide polymorphism in the SLC6A2 catecholamine transporter gene on blood pressure in caucasians. Journal of Clinical Hypertension (Greenwich, Conn.), 14(5), 293–298.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this entry
Cite this entry
Bayles, R., El-Osta, A. (2016). Genetics and Epigenetics in Cardiac Psychology. In: Alvarenga, M., Byrne, D. (eds) Handbook of Psychocardiology. Springer, Singapore. https://doi.org/10.1007/978-981-287-206-7_40
Download citation
DOI: https://doi.org/10.1007/978-981-287-206-7_40
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-287-205-0
Online ISBN: 978-981-287-206-7
eBook Packages: Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences